(PDF) Inhalation Aerosols 3rd Edition by Anthony J. Hickey

This is the PDF eBook version for Inhalation Aerosols – Physical and Biological Basis for Therapy 3rd Edition by Anthony J. Hickey, Heidi M. Mansour

Table of Contents

Section 1 Fundamentals

Physicochemical Properties of Respiratory Particles and Formulations
B. Shekunov

Particle Deposition in the Respiratory Tract and the Effect of Respiratory Disease
Dr. William Bennett

Mathematical Modeling of Inhaled Therapeutic Aerosol Deposition in the Respiratory Tract
Jeffry Schroeter, Bahman Asgharian, and Julia Kimbell

Lung transporters & absorption mechanisms in the lungs.
Mohammed Ali Selo,, Hassan H. A. Al-Alak, Carsten Ehrhardt

Bioavailability of inhaled compounds.
L. Garcia-Contreras

3D models as tools for inhaled drug development.
Sally-Ann Cryan, Jennifer Lorigan, Cian O’Leary

Overview of the delivery technologies for inhalation aerosols
Daniel F. Moraga-Espinoza, Ashlee D. Brunaugh, Silvia Ferrati, Lara A. Heersema, Matthew J. Herpin, Patricia P. Martins, Hairui Zhang, Hugh D. C. Smyth

Section 2 Applications, Influence of Lung Disease Pathophysiology on Aerosol Deposition, Inhaler Device Technique in Respiratory Disease, & Clinical Outcomes in Drug Performance Assessment

Neonatal & Pediatric Inhalation Drug Delivery
Ariel Berlinski

Asthma
Omar Usmani

Drug Delivery in Pulmonary Aspergillosis
Sawittree Sahakijpijarn, Jay I. Peters, Robert O. Williams III

Lung Cancer Inhalation Therapeutics
Rajiv Dhand

Inhaled Therapeutics in Chronic Obstructive Pulmonary Disease
Tejas Sinha, Paul DeJulio and Philip Diaz

Cystic fibrosis infection & Biofilm Busters
Jennifer Fiegel and Sachin Gharse

CURRENT AND FUTURE CFTR Therapeutics-
Marne C. Hagemeijer, Gimano D. Amatngalim and Jeffrey M. Beekman

Innate and Adaptive Barrier Properties of Airway Mucus
Alison Schaefer, Samuel K. Lai

Non-tuberculous mycobacteria (NTM)
M. Ghadiri, P. M. Young, and D. Traini

Inhalational Therapies for Non-CF Bronchiectasis
Ashvini Damodaran, Dustin R. Fraidenburg, and Israel Rubinstein

Pulmonary Fibrosis,
Priya Muralidharan, Dr. Don Hayes, Jr, and Dr. Heidi M. Mansour

Therapeutics in Pulmonary Hypertension
Maria F. Acosta, Don Hayes, Jr., Jeffrey R. Fineman, Jason X.-J. Yuan, Stephen M. Black, and Heidi M. Mansour

Respiratory distress syndrome,
Heidi M. Mansour, Debra Droopad, and Julie G. Ledford

Surfactant Aerosol Therapy for nRDS and ARDS
Donovan B. Yeates

Fundamentals in Nasal Drug Delivery
Zachary Warnken, Yu jin Kim, Heidi M. Mansour, Robert O. Williams III, Hugh D.C. Smyth

Inhaled therapeutics against TB: the promise of pulmonary treatment and prevention strategies in the clinic
Dominique N; Kunda, Nitesh K. Miller, Elliott K.; Muttil, Pavan

Section 3 Integrated strategies (reflecting combined elements from chapters 8-23):

Inhaled medication: factors that affect lung deposition
Joy Conway

A Critical Perspective on Future developments based on the knowledge we have now
Tania F. Bahamondez-Canas, Jasmim Leal, Hugh D.C. Smyth

26. Ensuring Effectiveness and Reproducibility of Inhaled Drug Treatment

Anthony J Hickey

27. Conclusion

A.J. Hickey, and H.M. Mansour